Internal Medicine, Hematology & Oncology · Fargo, ND
NPI
1508899139
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1702 University Dr S
Fargo, ND, 58103
Phone (701) 364-3300
Groups this clinician bills Medicare through
Medicare paid, 2024
$124K
2,420 services
Medicare patients, 2024
379
Average age 76
Drug cost, 2024
$4.1M
2,201 prescriptions
Company payments, 2025
$8,174
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mahendra K Gupta was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 633 times for 269 patients. In total Mahendra K Gupta billed 2,420 services in 25 codes, and Medicare paid $124K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-10-07.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 633 | 269 | $12.39 | $7,844 |
| 99214 Office E&M - Established | Facility | 435 | 221 | $67.89 | $30K |
| 99215 Office E&M - Established | Facility | 359 | 121 | $105.30 | $38K |
| 99232 Hospital E&M - Subsequent | Facility | 118 | 44 | $58.74 | $6,931 |
| 99223 Hospital E&M - Initial | Facility | 84 | 74 | $124.34 | $10K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 69 | 39 | $12.04 | $831 |
| 99214 Office E&M - Established | Office | 61 | 34 | $86.52 | $5,278 |
| 99233 Hospital E&M - Subsequent | Facility | 43 | 27 | $89.96 | $3,868 |
| 99205 Office E&M - New | Facility | 41 | 41 | $133.85 | $5,488 |
| 99213 Office E&M - Established | Facility | 17 | 17 | $35.30 | $600 |
By year: 2022 $126K for 1,973 services; 2023 $141K for 3,557 services; 2024 $124K for 2,420 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 68 | 29 | $10.51 | $715 |
| 85025 Blood Count | 66 | 30 | $7.74 | $511 |
| 36415 Venipuncture Blood Collection | 51 | 23 | $2.98 | $152 |
Medicare prescription drug claims, 2024
In 2024, the drug Mahendra K Gupta prescribed most often to Medicare patients was Dexamethasone, with 221 prescriptions and refills. In total Mahendra K Gupta wrote 2,201 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dexamethasone Generic | 221 | 224 | 64 | $1,084 |
| Anastrozole Generic | 176 | 345 | 33 | $2,865 |
| Prednisone Generic | 147 | 191 | 38 | $889 |
| Prochlorperazine Maleate Generic | 123 | 123 | 81 | $2,561 |
| Alendronate Sodium Generic | 91 | 204 | 24 | $629 |
| Abiraterone Acetate Generic | 80 | 80 | 14 | $99K |
| Levothyroxine Sodium Generic | 73 | 134 | 16 | $812 |
| Eliquis Apixaban | 64 | 74 | 12 | $43K |
| Gabapentin Generic | 61 | 86 | 18 | $570 |
| Hydroxyurea Generic | 59 | 82 | Under 11 | $1,100 |
| Olanzapine Generic | 59 | 61 | 24 | $192 |
| Ondansetron Hcl Generic | 46 | 46 | 32 | $290 |
| Tamoxifen Citrate Generic | 44 | 130 | 14 | $2,507 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 38 | 77 | 18 | $185 |
| Revlimid Lenalidomide | 37 | 37 | Under 11 | $789K |
Brand drugs: 366 claims; generic drugs: 1,835 claims; opioid claims: 110.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mahendra K Gupta $8,174 ($8,174 in general payments such as food, travel and fees) from 6 companies. The largest payer was Avyxa Pharma, LLC with $3,369.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.